ID

9963

Beschrijving

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Trefwoorden

  1. 08-03-15 08-03-15 -
  2. 09-03-15 09-03-15 -
  3. 24-04-15 24-04-15 -
  4. 09-07-15 09-07-15 - Martin Dugas
  5. 13-04-21 13-04-21 - Ahmed Rafee, MD
  6. 17-11-21 17-11-21 -
Geüploaded op

9 maart 2015

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0 Legacy

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Follow-up
Beschrijving

Follow-up

Consecutive Follow-up Number
Beschrijving

Follow up number

Datatype

integer

Alias
UMLS CUI-1
C1704685
Concomitant Disease
Beschrijving

Concomitant Disease

Alias
UMLS CUI-1
C0243087
Number
Beschrijving

Number

Datatype

integer

Alias
UMLS CUI-1
C0243087
UMLS CUI-2
C0237753
Date of Diagnosis
Beschrijving

Date of Diagnosis

Datatype

date

Alias
UMLS CUI-1
C0243087
Diagnosis
Beschrijving

Diagnosis

Datatype

text

Alias
UMLS CUI-1
C0243087
Therapy
Beschrijving

Therapy

Number
Beschrijving

Number

Datatype

integer

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0237753
Therapy after end of study
Beschrijving

Therapy after end of study

Datatype

integer

Alias
UMLS CUI-1
C0814259
Description of Therapy
Beschrijving

Description of Therapy

Datatype

text

Alias
UMLS CUI-1
C0087111
Start Date of Therapy
Beschrijving

Start Date of Therapy

Datatype

date

Alias
UMLS CUI-1
C0087111
Reason for Therapy
Beschrijving

Reason for Therapy

Datatype

integer

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0392360
Response before Therapy
Beschrijving

Response before Therapy

Datatype

integer

Alias
UMLS CUI-1
C0871261
Response after Therapy
Beschrijving

Response after Therapy

Datatype

integer

Alias
UMLS CUI-1
C0871261
Date of evaluation after therapy
Beschrijving

Date of evaluation after therapy

Datatype

date

Alias
UMLS CUI-1
C1261322
Allogenic Transplantation
Beschrijving

Allogenic Transplantation

Alias
UMLS CUI-1
C0149615
Date of Transplantation
Beschrijving

Date of Transplantation

Datatype

date

Alias
UMLS CUI-1
C0149615
Transplant
Beschrijving

Transplant

Datatype

integer

Alias
UMLS CUI-1
C0149615
HLA-Constellation
Beschrijving

HLA-Constellation

Datatype

integer

Alias
UMLS CUI-1
C0019627
Donor
Beschrijving

Donor

Datatype

integer

Alias
UMLS CUI-1
C0013018
Donor Comment
Beschrijving

Donor Comment

Datatype

text

Conditioning before transplant
Beschrijving

Conditioning before transplant

Datatype

text

Alias
UMLS CUI-1
C0376450
EBMT Identifier
Beschrijving

EBMT Identifier

Datatype

text

Alias
UMLS CUI-1
C0600091
Signature
Beschrijving

Signature

Date
Beschrijving

Date

Datatype

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Beschrijving

Name of Investigator

Datatype

text

Alias
UMLS CUI-1
C0008961
Signature of investigator
Beschrijving

Signature of investigator

Datatype

text

Alias
UMLS CUI-1
C2346576

Similar models

Follow-up AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Follow-up
Follow up number
Item
Consecutive Follow-up Number
integer
C1704685 (UMLS CUI-1)
Item Group
Concomitant Disease
C0243087 (UMLS CUI-1)
Number
Item
Number
integer
C0243087 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Date of Diagnosis
Item
Date of Diagnosis
date
C0243087 (UMLS CUI-1)
Diagnosis
Item
Diagnosis
text
C0243087 (UMLS CUI-1)
Item Group
Therapy
Number
Item
Number
integer
C0087111 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Item
Therapy after end of study
integer
C0814259 (UMLS CUI-1)
Code List
Therapy after end of study
CL Item
Chemotherapy (1)
CL Item
Allogenic Transplantation (as mentioned below) (2)
CL Item
other (3)
Description of Therapy
Item
Description of Therapy
text
C0087111 (UMLS CUI-1)
Start Date of Therapy
Item
Start Date of Therapy
date
C0087111 (UMLS CUI-1)
Item
Reason for Therapy
integer
C0087111 (UMLS CUI-1)
C0392360 (UMLS CUI-2)
Code List
Reason for Therapy
CL Item
Reinduction (1)
CL Item
Consolidation (2)
CL Item
Other (3)
Item
Response before Therapy
integer
C0871261 (UMLS CUI-1)
Code List
Response before Therapy
CL Item
CR (1)
CL Item
CRi (2)
CL Item
OR (3)
CL Item
RD (4)
CL Item
Relapse (5)
Item
Response after Therapy
integer
C0871261 (UMLS CUI-1)
Code List
Response after Therapy
CL Item
CR (1)
CL Item
CRi (2)
CL Item
PR (3)
CL Item
RD (4)
CL Item
Relapse (5)
Date of evaluation after therapy
Item
Date of evaluation after therapy
date
C1261322 (UMLS CUI-1)
Item Group
Allogenic Transplantation
C0149615 (UMLS CUI-1)
Date of Transplantation
Item
Date of Transplantation
date
C0149615 (UMLS CUI-1)
Item
Transplant
integer
C0149615 (UMLS CUI-1)
Code List
Transplant
CL Item
PBSCT (1)
CL Item
BM (KM) (2)
Item
HLA-Constellation
integer
C0019627 (UMLS CUI-1)
Code List
HLA-Constellation
CL Item
Full match (0)
CL Item
1 Mismatch (1)
CL Item
2 Mismatches (2)
CL Item
haplo (3)
Item
Donor
integer
C0013018 (UMLS CUI-1)
Code List
Donor
CL Item
family donor (1)
CL Item
unrelated donor (2)
Donor Comment
Item
Donor Comment
text
Conditioning before transplant
Item
Conditioning before transplant
text
C0376450 (UMLS CUI-1)
EBMT Identifier
Item
EBMT Identifier
text
C0600091 (UMLS CUI-1)
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial